The levels of GAS5 and NEF in the cancer tissues and serum of ESCC patients are significantly lower than those in normal individuals, and the levels of GAS5 and NEF also decrease with an increase in tumor stage (44, 48). This evidence concerns the gene GAS5 and cancer.